Overview

A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis

Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and efficacy of JNJ-39758979 in adult Japanese patients with moderate, active atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Pharmaceutical K.K.